Lactated Ringers, Intravenous — Competitive Intelligence Brief

Lactated Ringers, Intravenous (Lactated Ringers, Intravenous) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Crystalloid fluid replacement. Area: Critical Care / Fluid Management.

marketed Crystalloid fluid replacement Critical Care / Fluid Management Small molecule

Target snapshot

Lactated Ringers, Intravenous (Lactated Ringers, Intravenous) — Women and Infants Hospital of Rhode Island. Lactated Ringers is a crystalloid intravenous fluid that replaces lost fluids and electrolytes to restore intravascular volume and maintain hemodynamic stability.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Lactated Ringers, Intravenous TARGET	Lactated Ringers, Intravenous	Women and Infants Hospital of Rhode Island	marketed	Crystalloid fluid replacement
Plasma-Lyte A	Plasma-Lyte A	Michael A. Matthay	marketed	Crystalloid fluid replacement solution
standard saline infusion	standard saline infusion	University of Roma La Sapienza	marketed	Crystalloid fluid replacement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Crystalloid fluid replacement class)

1. University of Roma La Sapienza · 1 drug in this class
2. Women and Infants Hospital of Rhode Island · 1 drug in this class